Skip to main content
W

Wellell Inc. — Investor Relations & Filings

Ticker · 4106 TW Manufacturing
Open in API
Filings indexed 1,618 across all filing types
Latest filing 2026-05-04 Regulatory Filings
Country TW Taiwan
Listing TW 4106

About Wellell Inc.

https://tw.wellell.com/zh-tw

Wellell, formerly known as APEX Medical, is a global developer and manufacturer of medical solutions specializing in pressure relief and respiratory therapy. Established in 1990, the company focuses on improving the quality of life for patients and caregivers through advanced clinical equipment. Its core product portfolio includes medical air mattress systems for pressure injury prevention, continuous positive airway pressure (CPAP) devices for obstructive sleep apnea, and compression therapy systems for venous thromboembolism (VTE) intervention. Wellell integrates digital health technologies to create a Patient Recovery Care (PRC) ecosystem, enhancing treatment efficiency in both acute and post-acute care settings. With over 35 years of expertise, the company provides evidence-based medical devices and digital health services to support inpatient and outpatient recovery globally.

Recent filings

Filing Released Lang Actions
公告本公司115年第1季合併財務報告董事會 預計召開日期為115年5月12日
Regulatory Filings
2026-05-04 Chinese
114年第4季財務報告書 — 202504_4106_AIC.pdf
Audit Report / Information Classification · 1% confidence The document is the full Independent Auditors’ Report together with the parent company only financial statements for Wellell Inc. covering years 2025 and 2024, including audit opinion, basis of opinion, key audit matters, balance sheet, income statement, cash flows, notes, and disclosures. It is not a brief publication notice or an annual report, but the standalone audit report with financial statements, matching the definition of Audit Report / Information (Code AR).
2026-04-21 English
114年第4季財務報告書 — 202504_4106_AIA.pdf
Audit Report / Information Classification · 1% confidence The document is an independent auditor’s report titled “Audit Report for Consolidated Financial Statements 2025 and 2024,” including audit opinion, basis of audit, key audit matters, responsibilities, and detailed notes to consolidated financial statements. It is a standalone audit report, not a full annual report or earnings release. Therefore, it matches the definition of a standalone Audit Report / Information (Code: AR).
2026-04-21 English
114年第4季財務報告書 — 202504_4106_AI3.pdf
Regulatory Filings
2026-04-21 Chinese
115年3月背書保證與資金貸與
Regulatory Filings Classification · 1% confidence The document is a mandatory disclosure from Taiwan’s Market Observation Post System (“公開資訊觀測站”) providing tables of intercompany loan balances and endorsement/guarantee information. It is a standalone regulatory schedule of contingent liabilities and financing/guarantee data—not an earnings release, not a full quarterly or annual report, nor a management presentation or capital issuance notice. It does not attach a separate report but itself constitutes the filing. This aligns with the fallback “Regulatory Filings” category.
2026-04-10 Chinese
115年3月營業收入
Regulatory Filings Classification · 1% confidence The document is a monthly operating revenue summary provided by a listed company via Taiwan’s public information observatory (MOPS). It presents actual revenue figures and IFRS notes rather than announcing or attaching another report. There is no specific category for monthly revenue statements, and it does not match categories like annual/quarterly reports, earnings releases, or management presentations. Therefore, it falls under the fallback Regulatory Filings category.
2026-04-10 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.